Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.400 | None | 0.920 | 364 | 3 | 1994 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.959 | 268 | 3 | 1990 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.400 | None | 0.971 | 245 | 4 | 1989 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.400 | None | 0.924 | 157 | 4 | 2003 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.400 | None | 0.975 | 118 | 1 | 2005 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.400 | None | 0.979 | 47 | 0 | 2002 | 2019 | ||||||||
|
microRNA 143 | 0.462 | 0.885 |
|
phenotype | 0.400 | None | 1.000 | 23 | 1 | 2006 | 2019 | |||||||||
|
microRNA 203a | 0.471 | 0.808 |
|
phenotype | 0.400 | None | 1.000 | 16 | 0 | 2013 | 2019 | |||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.900 | 10 | 0 | 1993 | 2019 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
phenotype | 0.370 | None | 0.857 | 7 | 0 | 2002 | 2018 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
phenotype | 0.330 | None | 1.000 | 4 | 0 | 2012 | 2017 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 0.981 | 54 | 1 | 1999 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
phenotype | 0.300 | None | 1.000 | 21 | 2 | 2007 | 2020 | ||||||||
|
small nucleolar RNA, C/D box 50A |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.100 | None | 0.962 | 1455 | 23 | 1990 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.967 | 483 | 0 | 1997 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 0.967 | 360 | 5 | 1986 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.977 | 347 | 0 | 1996 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.982 | 335 | 1 | 2000 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 283 | 0 | 2000 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.100 | None | 0.947 | 281 | 1 | 1997 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 0.992 | 265 | 1 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.992 | 260 | 1 | 2000 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.992 | 259 | 0 | 2000 | 2020 |